Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 105

1.

The European Respiratory Society's 10 Principles for Lung Health.

Horváth I, Barry M, Brusselle G, Burghuber OC, Bush A, Robalo Cordeiro C, Gaga M, Gratziou C, Saraiva I, Stolz D, Troosters T, Welte T, Migliori GB, Joos G.

Eur Respir J. 2018 Nov 29;52(5). pii: 1801373. doi: 10.1183/13993003.01373-2018. Print 2018 Nov. No abstract available.

PMID:
30498051
2.

The LEAD (Lung, Heart, Social, Body) Study: Objectives, Methodology, and External Validity of the Population-Based Cohort Study.

Breyer-Kohansal R, Hartl S, Burghuber OC, Urban M, Schrott A, Agusti A, Sigsgaard T, Vogelmeier C, Wouters E, Studnicka M, Breyer MK.

J Epidemiol. 2018 Oct 20. doi: 10.2188/jea.JE20180039. [Epub ahead of print]

3.

The European Respiratory Society: ensuring excellence through education best practice.

Farr A, Gaga M, Welte T, Troosters T, Joos G, Robalo Cordeiro C, Burghuber OC, Brusselle G, Gratziou CG, Bush A, Saraiva I, Pannetier C, Stolz D.

Eur Respir J. 2018 Sep 15;52(3). pii: 1801248. doi: 10.1183/13993003.01248-2018. Print 2018 Sep. No abstract available.

PMID:
30219751
4.

Long-term outcomes after acute hypercapnic COPD exacerbation : First-ever episode of non-invasive ventilation.

Fazekas AS, Aboulghaith M, Kriz RC, Urban M, Breyer MK, Breyer-Kohansal R, Burghuber OC, Hartl S, Funk GC.

Wien Klin Wochenschr. 2018 Oct;130(19-20):561-568. doi: 10.1007/s00508-018-1364-6. Epub 2018 Jul 31.

5.

Phenotypes of COPD in an Austrian population : National data from the POPE study.

Reiger G, Zwick R, Lamprecht B, Kähler C, Burghuber OC, Valipour A.

Wien Klin Wochenschr. 2018 Jun;130(11-12):382-389. doi: 10.1007/s00508-018-1347-7. Epub 2018 May 24.

PMID:
29797071
6.

Cell-Free Plasma DNA-Guided Treatment With Osimertinib in Patients With Advanced EGFR-Mutated NSCLC.

Buder A, Hochmair MJ, Schwab S, Bundalo T, Schenk P, Errhalt P, Mikes RE, Absenger G, Patocka K, Baumgartner B, Setinek U, Burghuber OC, Prosch H, Pirker R, Filipits M.

J Thorac Oncol. 2018 Jun;13(6):821-830. doi: 10.1016/j.jtho.2018.02.014. Epub 2018 Mar 2.

PMID:
29505901
7.

Symptomatic pseudo-progression followed by significant treatment response in two lung cancer patients treated with immunotherapy.

Hochmair MJ, Schwab S, Burghuber OC, Krenbek D, Prosch H.

Lung Cancer. 2017 Nov;113:4-6. doi: 10.1016/j.lungcan.2017.08.020. Epub 2017 Aug 31.

PMID:
29110847
8.

Taken to task: what is and is not an appropriate response to an ERS guidelines task force?

Joos G, Bush A, Burghuber OC, Robalo Cordeiro C, Gaga M, Gibson GJ, Gratziou C, Rigau D, Rohde G, Smyth D, Stolz D, Tonia T, Vestbo J, Welte T, Brusselle G, Miravitlles M.

Eur Respir J. 2017 Jul 13;50(1). pii: 1700952. doi: 10.1183/13993003.00952-2017. Print 2017 Jul. No abstract available.

PMID:
28705948
9.

Increased brachial intima-media thickness is associated with circulating levels of asymmetric dimethylarginine in patients with COPD.

Urban MH, Eickhoff P, Funk GC, Burghuber OC, Wolzt M, Valipour A.

Int J Chron Obstruct Pulmon Dis. 2017 Jan 4;12:169-176. doi: 10.2147/COPD.S118596. eCollection 2017.

10.

Complete remissions in afatinib-treated non-small-cell lung cancer patients with symptomatic brain metastases.

Hochmair M, Holzer S, Burghuber OC.

Anticancer Drugs. 2016 Oct;27(9):914-5. doi: 10.1097/CAD.0000000000000410.

PMID:
27442131
11.

The European Respiratory Society evaluates its 2013-2018 strategic plan implementation.

Migliori GB, Bel E, Joos G, Elliott M, Rohde G, Holgate ST, Gratziou C, Smyth D, Gaga M, Cordeiro CR, Burghuber OC, Brusselle G, Martin-Burrieza F, Bill W, Sax B, Vestbo J.

Eur Respir J. 2016 Mar;47(3):693-8. doi: 10.1183/13993003.02110-2015. No abstract available.

12.

An update on the efficacy of endobronchial valve therapy in the management of hyperinflation in patients with chronic obstructive pulmonary disease.

Valipour A, Burghuber OC.

Ther Adv Respir Dis. 2015 Dec;9(6):294-301. doi: 10.1177/1753465815599693. Epub 2015 Aug 20. Review.

PMID:
26294417
13.

[The Austrian LEAD (Lung hEart sociAL boDy) Study: Background of the Austrian Longitudinal Cohort Study].

Breyer-Kohansal R, Breyer MK, Hartl S, Burghuber OC.

Pneumologie. 2015 Aug;69(8):459-62. doi: 10.1055/s-0034-1392516. Epub 2015 Aug 10. Review. German.

PMID:
26258419
14.

Tobacco addiction and smoking cessation in Austrian migrants: a cross-sectional study.

Urban M, Burghuber OC, Dereci C, Aydogan M, Selimovic E, Catic S, Funk GC.

BMJ Open. 2015 Jun 4;5(6):e006510. doi: 10.1136/bmjopen-2014-006510.

15.

Effectiveness and safety of ciclesonide in the treatment of patients with persistent allergic or non-allergic asthma in medical practice (Data from a non-interventional study conducted in Austria).

Burghuber OC, Köberl G, Lenk-Feik S, Schantl M, Sander P, Hammer A.

Wien Klin Wochenschr. 2014 Sep;126(17-18):537-48. doi: 10.1007/s00508-014-0576-7. Epub 2014 Aug 15.

PMID:
25123142
16.

Soluble receptor of advanced glycation end-products and endothelial dysfunction in COPD.

Urban MH, Valipour A, Kiss D, Eickhoff P, Funk GC, Burghuber OC.

Respir Med. 2014 Jun;108(6):891-7. doi: 10.1016/j.rmed.2014.03.013. Epub 2014 Apr 2.

17.

Insulin resistance may contribute to vascular dysfunction in patients with chronic obstructive pulmonary disease.

Urban MH, Ay L, Funk GC, Burghuber OC, Eickhoff P, Wolzt M, Valipour A.

Wien Klin Wochenschr. 2014 Feb;126(3-4):106-12. doi: 10.1007/s00508-013-0478-0. Epub 2013 Dec 17.

PMID:
24343042
18.

Target lobe volume reduction and COPD outcome measures after endobronchial valve therapy.

Valipour A, Herth FJ, Burghuber OC, Criner G, Vergnon JM, Goldin J, Sciurba F, Ernst A; VENT Study Group.

Eur Respir J. 2014 Feb;43(2):387-96. doi: 10.1183/09031936.00133012. Epub 2013 Jul 11.

19.

A case of tracheobronchial amyloidosis treated with endoscopic debulking and external beam radiation therapy.

Firlinger I, Setinek U, Koller H, Feurstein P, Prosch H, Burghuber OC, Valipour A.

Pneumologie. 2013 Jul;67(7):398-400. doi: 10.1055/s-0033-1344186. Epub 2013 Jul 4.

20.

Endoscopic one-way valve implantation in patients with prolonged air leak and the use of digital air leak monitoring.

Firlinger I, Stubenberger E, Müller MR, Burghuber OC, Valipour A.

Ann Thorac Surg. 2013 Apr;95(4):1243-9. doi: 10.1016/j.athoracsur.2012.12.036. Epub 2013 Feb 21.

PMID:
23434254
21.

Prevalence and prognosis of COPD in critically ill patients between 1998 and 2008.

Funk GC, Bauer P, Burghuber OC, Fazekas A, Hartl S, Hochrieser H, Schmutz R, Metnitz P.

Eur Respir J. 2013 Apr;41(4):792-9. doi: 10.1183/09031936.00226411. Epub 2012 Sep 27.

22.

Active tuberculosis is characterized by an antigen specific and strictly localized expansion of effector T cells at the site of infection.

Nemeth J, Rumetshofer R, Winkler HM, Burghuber OC, Müller C, Winkler S.

Eur J Immunol. 2012 Nov;42(11):2844-50. doi: 10.1002/eji.201242678. Epub 2012 Sep 20.

23.

Peripheral T cell cytokine responses for diagnosis of active tuberculosis.

Nemeth J, Winkler HM, Zwick RH, Müller C, Rumetshofer R, Boeck L, Burghuber OC, Winkler S.

PLoS One. 2012;7(4):e35290. doi: 10.1371/journal.pone.0035290. Epub 2012 Apr 16.

24.

Clinical highlights from the 2011 ERS Congress in Amsterdam.

Spruit MA, Chavannes NH, Herth FJ, Poletti V, Ley S, Burghuber OC, Clini E, Cottin V.

Eur Respir J. 2012 Jun;39(6):1501-10. doi: 10.1183/09031936.00217111. Epub 2012 Mar 9.

25.

[A leak in the lung: endobronchial one-way valve placement as treatment for a persistent bronchopleural fistula].

Seyfried U, Firlinger I, Reiter M, Katz-Papatheophilou E, Koller H, Burghuber OC, Valipour A.

Pneumologie. 2012 Mar;66(3):188-91. doi: 10.1055/s-0031-1291615. Epub 2012 Jan 27. German.

26.

The European Respiratory Society spirometry tent: a unique form of screening for airway obstruction.

Maio S, Sherrill DL, MacNee W, Lange P, Costabel U, Dahlén SE, Sybrecht GW, Burghuber OC, Stevenson R, Tønnesen P, Haeussinger K, Hedlin G, Bauer TT, Riedler J, Nicod L, Carlsen KH, Viegi G; European Respiratory Society/European Lung Foundation Spirometry Tent Working Group.

Eur Respir J. 2012 Jun;39(6):1458-67. doi: 10.1183/09031936.00111910. Epub 2012 Jan 20.

27.

Hypoxemia and cardiovascular disease in COPD. Not related to sleep disordered breathing after all.

Valipour A, Burghuber OC.

Sleep Med. 2012 Feb;13(2):214. doi: 10.1016/j.sleep.2011.05.013. Epub 2011 Dec 3. No abstract available.

PMID:
22137106
28.

Sleep profile and symptoms of sleep disorders in patients with stable mild to moderate chronic obstructive pulmonary disease.

Valipour A, Lavie P, Lothaller H, Mikulic I, Burghuber OC.

Sleep Med. 2011 Apr;12(4):367-72. doi: 10.1016/j.sleep.2010.08.017.

PMID:
21388878
29.

Long-term non-invasive ventilation in COPD after acute-on-chronic respiratory failure.

Funk GC, Breyer MK, Burghuber OC, Kink E, Kirchheiner K, Kohansal R, Schmidt I, Hartl S.

Respir Med. 2011 Mar;105(3):427-34. doi: 10.1016/j.rmed.2010.09.005. Epub 2010 Nov 26.

30.

Nordic walking improves daily physical activities in COPD: a randomised controlled trial.

Breyer MK, Breyer-Kohansal R, Funk GC, Dornhofer N, Spruit MA, Wouters EF, Burghuber OC, Hartl S.

Respir Res. 2010 Aug 22;11:112. doi: 10.1186/1465-9921-11-112.

31.

Knowing chronic obstructive pulmonary disease by heart: cumulating evidence of systemic vascular dysfunction.

Burghuber OC, Valipour A.

Am J Respir Crit Care Med. 2009 Sep 15;180(6):487-8. doi: 10.1164/rccm.200907-1037ED. No abstract available.

PMID:
19734349
32.

Incidence and outcome of weaning from mechanical ventilation according to new categories.

Funk GC, Anders S, Breyer MK, Burghuber OC, Edelmann G, Heindl W, Hinterholzer G, Kohansal R, Schuster R, Schwarzmaier-D'Assie A, Valentin A, Hartl S.

Eur Respir J. 2010 Jan;35(1):88-94. doi: 10.1183/09031936.00056909. Epub 2009 Jun 18.

33.

[The effect of one year outpatient pulmonary rehabilitation on patients with COPD].

Zwick RH, Burghuber OC, Dovjak N, Hartl S, Kössler W, Lichtenschopf A, Müller R, Zwick H.

Wien Klin Wochenschr. 2009;121(5-6):189-95. doi: 10.1007/s00508-008-1066-6. German.

PMID:
19412748
34.

Short-term effects of inhaled salbutamol on autonomic cardiovascular control in healthy subjects: a placebo-controlled study.

Cekici L, Valipour A, Kohansal R, Burghuber OC.

Br J Clin Pharmacol. 2009 Apr;67(4):394-402. doi: 10.1111/j.1365-2125.2009.03377.x.

35.

Measuring FEV(6) for detecting early airway obstruction in the primary care setting. Quality and utility of the new PiKo-6 device.

Kaufmann M, Hartl S, Geyer K, Breyer MK, Burghuber OC.

Respiration. 2009;78(2):161-7. doi: 10.1159/000197466. Epub 2009 Jan 28.

PMID:
19174602
36.

BODE index versus GOLD classification for explaining anxious and depressive symptoms in patients with COPD - a cross-sectional study.

Funk GC, Kirchheiner K, Burghuber OC, Hartl S.

Respir Res. 2009 Jan 9;10:1. doi: 10.1186/1465-9921-10-1.

37.

Comparison of daily physical activity between COPD patients from Central Europe and South America.

Pitta F, Breyer MK, Hernandes NA, Teixeira D, Sant'Anna TJ, Fontana AD, Probst VS, Brunetto AF, Spruit MA, Wouters EF, Burghuber OC, Hartl S.

Respir Med. 2009 Mar;103(3):421-6. doi: 10.1016/j.rmed.2008.09.019. Epub 2008 Nov 9.

38.

Determinants of systemic vascular function in patients with stable chronic obstructive pulmonary disease.

Eickhoff P, Valipour A, Kiss D, Schreder M, Cekici L, Geyer K, Kohansal R, Burghuber OC.

Am J Respir Crit Care Med. 2008 Dec 15;178(12):1211-8. doi: 10.1164/rccm.200709-1412OC. Epub 2008 Oct 3.

PMID:
18836149
39.

[The use of erythropoiesis-stimulating proteins in anemic patients with malignant diseases].

Osterreichische Konsensus-Gruppe zum Einsatz von Erythropoese-stimulierenden Proteinen bei Chemotherapie-induzierter Anämie, unter der Schirmherrschaft der OGHO, Ludwig H, Auberger T, Burghuber OCh, Gnant M, Hopfinger G, Jäger U, Keil F, Kornek G, Linkesch W, Petru E, Pirker R, Pittermann E, Reinthaller A, Samonigg H, Steger G, Stockenhuber F, Studnicka M, Weiss G, Zielinski C.

Wien Klin Wochenschr. 2008;120(15-16):507-13. doi: 10.1007/s00508-008-1007-4. German. No abstract available.

PMID:
18820857
40.

[The Viennese Clinical Weekly and the Austrian Society for Pneumology].

Burghuber OC.

Wien Klin Wochenschr. 2008;120(15-16):452-3. doi: 10.1007/s00508-008-1028-z. German. No abstract available.

PMID:
18820844
41.

Recruitment of Mycobacterium tuberculosis specific CD4+ T cells to the site of infection for diagnosis of active tuberculosis.

Nemeth J, Winkler HM, Zwick RH, Rumetshofer R, Schenk P, Burghuber OC, Graninger W, Ramharter M, Winkler S.

J Intern Med. 2009 Jan;265(1):163-8. doi: 10.1111/j.1365-2796.2008.02012.x. Epub 2008 Sep 10.

42.

Left ventricular diastolic dysfunction in patients with COPD in the presence and absence of elevated pulmonary arterial pressure.

Funk GC, Lang I, Schenk P, Valipour A, Hartl S, Burghuber OC.

Chest. 2008 Jun;133(6):1354-1359. doi: 10.1378/chest.07-2685. Epub 2008 Mar 13.

PMID:
18339780
43.

Circulating vascular endothelial growth factor and systemic inflammatory markers in patients with stable and exacerbated chronic obstructive pulmonary disease.

Valipour A, Schreder M, Wolzt M, Saliba S, Kapiotis S, Eickhoff P, Burghuber OC.

Clin Sci (Lond). 2008 Oct;115(7):225-32. doi: 10.1042/CS20070382.

PMID:
18307413
44.
45.

[Examination of pulmonary circulation using right heart catheterization. Position paper of the Cardiopulmonary Task Force of the Austrian Society for Pneumology and the Austrian Society for Cardiology].

Schenk P, Stiebellehner L, Burghuber OC, Kneussl M, Lang IM; Austrian Society for Pneumology; Austrian Society for Cardiology.

Wien Klin Wochenschr. 2005 Sep;117(18):651-62. German. No abstract available.

PMID:
16416349
46.

Pleural empyema associated with Gemella morbillorum: report of a case and review of the literature.

Valipour A, Koller H, Setinek U, Burghuber OC.

Scand J Infect Dis. 2005;37(5):378-81. Review.

PMID:
16051579
47.

Heart rate variability and spontaneous baroreflex sequences in supine healthy volunteers subjected to nasal positive airway pressure.

Valipour A, Schneider F, Kössler W, Saliba S, Burghuber OC.

J Appl Physiol (1985). 2005 Dec;99(6):2137-43. Epub 2005 Jul 7.

48.

Bronchoscopy-guided topical hemostatic tamponade therapy for the management of life-threatening hemoptysis.

Valipour A, Kreuzer A, Koller H, Koessler W, Burghuber OC.

Chest. 2005 Jun;127(6):2113-8.

PMID:
15947328
49.

[The diagnosis of COPD].

Hartl S, Burghuber OC.

Wien Med Wochenschr. 2005 Mar;155(5-6):90-4. German.

PMID:
15884488
50.

[Chronic obstructive pulmonary disease].

Burghuber OC.

Wien Med Wochenschr. 2005 Mar;155(5-6):77. German. No abstract available.

PMID:
15884484

Supplemental Content

Loading ...
Support Center